Fig. 5From: Tumor suppression effect of ultrasound-sensitive nanoparticles with focused ultrasound in a pancreas cancer xenograft modelTumor growth rate in synergistic effect experiment. Contrary to the IMP301 4 mg/kg only group, the IMP301 4 mg/kg with FUS group showed significantly lower tumor growth rate compared to all the other groups and the difference was only significant when irradiated with FUS (p < 0.050; statistical significance indicated as asterisk, *). DOX Doxil, FUS Focused ultrasound, GEM Gemcitabine, IMP301 Doxorubicin HCl-loaded liposome, IMP4 4 mg/kg IMP301, C ControlBack to article page